The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...
Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...
A new study in mice suggests that long-term exposure to low levels of traffic-related air pollution can damage the liver and ...
Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases in the U.S.
The beef extract is enjoying a resurgence thanks to the popularity of high-protein diets, but it might not be as healthy as ...
More than a million Brits could be living with undiagnosed diabetes, with early detection being key to managing the condition and maintaining a good quality of life ...
Counteract sedentary habits by incorporating at least 150 minutes of moderate exercise per week, such as walking, cycling, ...
The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
Making the change can lower LDL cholesterol levels, keep blood sugar under control and promote better heart health ...
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
Following her death, a funeral notice published in the Western Morning News described Ms Jeffery as a "dearly loved mum" to ...
Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval allows doctors to prescribe Ozempic specifically to lower the risk of kidney ...